Loading…
S. 2903119th CongressIn committeeLatest action Mar 19, 2026Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
The Safe Step Act would require employer health plans to allow timely exceptions to step therapy drug rules under specific medical conditions.
45-second read · 4 questions answered below
The Safe Step Act would require employer-sponsored health plans to create a clear, timely process for patients or doctors to request exceptions to step therapy requirements. Plans would have to grant exceptions in certain medical situations, respond within 72 hours (24 in urgent cases), and cover approved exceptions for at least a year. Plans would also have to publish information on the process and report annual data on requests and approvals.
The bill mainly affects people with employer-based health insurance regulated under federal ERISA law, especially patients with chronic illnesses or conditions needing specialized medications. It also affects insurers, employers sponsoring health plans, and doctors who request exceptions on patients' behalf.
Insurers and employers would need to build new appeals and reporting systems, changing how coverage decisions for certain medications are handled and documented.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Committee on Health, Education, Labor, and Pensions. Hearings held.